Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'20
Mar'19
Mar'18
Mar'17
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 894.04% vs NA in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 111.45% vs NA in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 0.00% vs NA in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is 2,463.81% vs NA in Mar 2025
Compare Profit and Loss Results of Venmax Drugs
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
8.00
14.00
-6.00
-42.86%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
8.00
14.00
-6.00
-42.86%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
8.00
10.00
-2.00
-20.00%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
0.00
1.00
-1.00
-100.00%
Operating Expenses
0.00
1.00
-1.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
7.00
13.00
-6.00
-46.15%
Operating Profit (PBDIT) excl Other Income
0.00
0.00
0.00
0%
Other Income
0.00
0.00
0.00
0%
Operating Profit (PBDIT)
0.00
1.00
-1.00
-100.00%
Interest
0.00
0.00
0.00
0%
Profit before Depriciation and Tax
0.00
1.00
-1.00
-100.00%
Depreciation
0.00
0.00
0.00
0%
Profit Before Taxation & Exceptional Items
0.00
1.00
-1.00
-100.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
0.00
1.00
-1.00
-100.00%
Provision for Tax
0.00
0.00
0.00
0%
Profit After Tax
0.00
0.00
0.00
0%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
-5.00
7.00
-12.00
-171.43%
Profit Available for appropriations
-5.00
8.00
-13.00
-162.50%
Appropriations
-5.00
8.00
-13.00
-162.50%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
0.21
2.6
-2.39
-91.92%
Profit And Loss - Net Sales
Net Sales 8.02 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 894.04% vs NA in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 0.12 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 111.45% vs NA in Mar 2025
Profit And Loss - Interest
Interest 0.00 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 0.00% vs NA in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax 0.25 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 2,463.81% vs NA in Mar 2025






